Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02176148 · ClinicalTrials.gov registry record
Cutaneous Lupus Medication Experience Study
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 11
- Enrollment target
NCT02176148 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 11 participants.
The verdict
NCT02176148 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
Cutaneous lupus is a chronic, relapsing, auto-immune skin disease that can have many presentations. Its effect on physical appearance greatly affects patients' quality of life. In addition, 10% of patients with cutaneous lupus will develop systemic lupus. Topical therapies are the mainstay of cutaneous lupus treatment; however patients often find these treatments to be messy, inconvenient, or ineffective. In addition, for more severe disease patients are often placed on concurrent systemic therapies. The primary hypothesis of our study is that poor adherence contributes to poor treatment outcomes in patients with cutaneous lupus.
Interventions
- DRUG fluocinonide 0.05% cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2014-12 |
| Est. Completion | 2020-12-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02176148
The ClinicalTrials.gov registry entry for NCT02176148 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which fluocinonide 0.05% cream is the first listed.
NCT02176148 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02176148 about?
NCT02176148 is a clinical study titled "Cutaneous Lupus Medication Experience Study". Cutaneous lupus is a chronic, relapsing, auto-immune skin disease that can have many presentations. Its effect on physical appearance greatly affects patients' quality of life. In addition, 10% of patients with cutaneous lupus will develop systemic lupus. Topical therapies are the mainstay of cutane...
What is the current status of trial NCT02176148?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2014-12. Estimated completion is 2020-12-04.
What interventions are being tested in trial NCT02176148?
The interventions under investigation include: fluocinonide 0.05% cream (DRUG).
Who is sponsoring clinical trial NCT02176148?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.